<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-17848" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Arteriovenous Malformations of the Central Nervous System</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Zyck</surname>
            <given-names>Stephanie</given-names>
          </name>
          <aff>SUNY Upstate Medical University</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Davidson</surname>
            <given-names>Caroline L.</given-names>
          </name>
          <aff>University of Nebraska Medical Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Sampath</surname>
            <given-names>Raghuram</given-names>
          </name>
          <aff>Florida Atlantic University Advanced Neuroscience Network</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Stephanie Zyck declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Caroline Davidson declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Raghuram Sampath declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>4</day>
          <month>3</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-17848.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Arteriovenous malformations (AVMs) are abnormal fistulas between arteries and veins without an intervening capillary bed. High arterial flow directly into venous structures can lead to disruption of the venous walls and ultimately cause fatal hemorrhage. Intracranial AVMs are most commonly diagnosed during evaluation for an acute intracerebral hemorrhage but may be incidental findings uncovered during the assessment of conditions such as chronic headaches and seizures. Interventions for AVMs of the central nervous system are associated with increased mortality&#x000a0;rates; risk stratification for surgical versus nonsurgical treatment is critical.&#x000a0;</p>
        <p>Spinal AVMs most often present with progressive back and leg pain accompanied by neurologic deficits secondary to mass effect or ischemic injury; an acutely hemorrhagic presentation is also possible. Preventing the acute hemorrhage of a central nervous system AVM and subsequent neurologic injury requires an accurate diagnosis and the timely intervention of a multidisciplinary team.</p>
        <p>This activity for healthcare professionals reviews the etiology, epidemiology, pathophysiology, clinical presentation, evaluation, and management of central nervous system AVMs. The activity also highlights the critical role of the interprofessional team in improving outcomes for patients with these congenital vascular lesions.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify patients who may have a ruptured or unruptured arteriovenous malformation of the central nervous system based on their clinical presentation.</p></list-item><list-item><p>Determine the most appropriate imaging study for a patient with a suspected arteriovenous malformation of the central nervous system.</p></list-item><list-item><p>Apply the Spetzler-Martin Arteriovenous Malformation Grading&#x000a0;System into clinical practice as a decision-making guide when determining the most appropriate intervention for a patient with an intracranial arteriovenous malformation.&#x000a0;</p></list-item><list-item><p>Develop and implement effective interprofessional team strategies to improve outcomes for patients with ruptured and unruptured arteriovenous malformations of the central nervous system.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=17848&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=17848">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-17848.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>An arteriovenous malformation (AVM) is an abnormal connection between arterial and venous vessels without intervening capillary structures. The lack of capillary components leads to arterialized veins in a high-flow, low-resistance shunt system.<xref ref-type="bibr" rid="article-17848.r1">[1]</xref><bold>&#x000a0;</bold>Cerebral AVMs convey a 1% annual risk of epilepsy and a 3% annual risk of hemorrhage.<xref ref-type="bibr" rid="article-17848.r2">[2]</xref>&#x000a0;The risk of hemorrhage comprises a 2% annual risk for unruptured AVMs and a 4.5% annual risk for previously ruptured AVMs.&#x000a0;</p>
        <p>Intracranial AVMs vary significantly in size, location, and vascular flow dynamics. AVMs are most commonly identified within the cerebral cortex, the brainstem (pons and midbrain), and the cerebellum.<xref ref-type="bibr" rid="article-17848.r2">[2]</xref>&#x000a0;AVMs are also seen in the&#x000a0;spinal cord.<xref ref-type="bibr" rid="article-17848.r2">[2]</xref>&#x000a0;The Spetzler-Martin grading scale is a commonly&#x000a0;utilized classification system&#x000a0;for intracranial AVMs. Refer to <bold>"Spetzler-Martin Arteriovenous Malformation Grading System" </bold>in the&#x000a0;<bold>Evaluation</bold> section for more information on this classification system.&#x000a0;As the Spetzler-Martin grade increases, so does the surgical morbidity and mortality risk.</p>
        <p>Spinal AVMs are subclassified as intramedullary, perimedullary, or both.&#x000a0;Spinal AVMs may be direct or true nidal fistulas and high- or low-flow. A direct fistula is a direct connection between an artery or vein, most commonly at the dural sinuses. In contrast, a nidal fistula connects the artery and vein through a network of small noncapillary vessels. The Kim-Spetzler classification system&#x000a0;describes 4 types of spinal AVMs.<xref ref-type="bibr" rid="article-17848.r3">[3]</xref>&#x000a0;Type I is an intradural dorsal arteriovenous fistula, type II is an intramedullary AVM, type III is an extradural-intradural AVM, and type IV is an intradural ventral arteriovenous fistula. More recent classification systems describe a fifth type of lesion within the conus medullaris.&#x000a0;</p>
        <p>Direct fistulas comprise 20% of spinal AVMs and are commonly located on the surface of the spinal cord. True nidal spinal AVMs are more common&#x000a0;and constitute 80% of cases; the nidus is typically intramedullary.<xref ref-type="bibr" rid="article-17848.r4">[4]</xref>&#x000a0;Pediatric patients more commonly present with arteriovenous fistula pathophysiology, and adults more commonly present with true nidal spinal AVMs. Spinal AVMs often present&#x000a0;with&#x000a0;chronic progressive neurologic deficits or hemorrhage leading to acute back pain with lower extremity pain, paresthesias, motor weakness, or bowel or bladder dysfunction.<xref ref-type="bibr" rid="article-17848.r4">[4]</xref>&#x000a0;Approximately 50% of spinal AVMs are located within the thoracic spine; another 30% are within the cervical spine.<xref ref-type="bibr" rid="article-17848.r5">[5]</xref></p>
      </sec>
      <sec id="article-17848.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Though the exact mechanism of AVM formation is not fully understood, they are believed to form secondary to an abnormal arrest during embryologic vascular development. Approximately 5% of AVMs are identified in patients with inherited disorders such as autosomal dominant hereditary hemorrhagic telangiectasia, also known as Osler-Weber-Rendu syndrome.<xref ref-type="bibr" rid="article-17848.r6">[6]</xref><xref ref-type="bibr" rid="article-17848.r7">[7]</xref>&#x000a0;Capillary malformation-arteriovenous malformation (CM-AVM) syndrome is a more recently described systemic disorder of autosomal dominant inheritance with multiple small AVMs in the limbs and face.<xref ref-type="bibr" rid="article-17848.r7">[7]</xref>&#x000a0;</p>
        <p>Multiple genetic mutations have been noted in patients with sporadic AVMs, including somatic activating KRAS mutations, the stop-gain mutation in SMAD9, and an increase in Notch-3 receptor expression.<xref ref-type="bibr" rid="article-17848.r8">[8]</xref><xref ref-type="bibr" rid="article-17848.r9">[9]</xref><xref ref-type="bibr" rid="article-17848.r10">[10]</xref>&#x000a0;Increased KRAS activity leads to increased MAPK/ERK pathway activity with downstream elevations in Notch signaling and angiogenesis factors.<xref ref-type="bibr" rid="article-17848.r8">[8]</xref>&#x000a0;A significantly lower level of SMAD9 in AVM vessels was observed, as well as a decrease in SMAD4 phosphorylation. SMAD4 is a downstream factor in the MAPK/ERK pathway.<xref ref-type="bibr" rid="article-17848.r9">[9]</xref>&#x000a0;In 2015, Hill-Fellberg et al discovered a significant increase in Notch-3 receptor expression in AVM vasculature compared to brain samples without AVM. In addition, they found a significant decrease in Notch-1 and an increase in Notch-4 receptors.<xref ref-type="bibr" rid="article-17848.r10">[10]</xref>&#x000a0;More recently, in 2020, Hauer et al evaluated genetic alterations in AVMs via next-generation RNA sequencing of 12 AVMs compared to 16 healthy controls. Over 700 genes were upregulated in the AVM samples, including those involved in transforming growth factor-&#x003b2; (TGF-&#x003b2;) signaling, the extracellular matrix composition, inflammation, and the angiotensin-Tie pathway.<xref ref-type="bibr" rid="article-17848.r11">[11]</xref></p>
        <p>AVMs also occur within the spinal canal, comprising 3% to 4% of all space-occupying spinal lesions and 5% to 9% of all central nervous system vascular malformations.<xref ref-type="bibr" rid="article-17848.r12">[12]</xref>&#x000a0;Patients with hereditary hemorrhagic telangiectasia are also predisposed to spinal AVMs.<xref ref-type="bibr" rid="article-17848.r5">[5]</xref>&#x000a0;Other genetic syndromes with a predisposition to spinal AVMs are Klippel-Trenaunay syndrome, Parkes-Weber Syndrome, and the spinal arteriovenous metameric Cobb Syndrome.<xref ref-type="bibr" rid="article-17848.r4">[4]</xref></p>
      </sec>
      <sec id="article-17848.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Up to&#x000a0;88% of intracranial AVMs are asymptomatic. Of those symptomatic, 45% present with hemorrhage.<xref ref-type="bibr" rid="article-17848.r13">[13]</xref>&#x000a0;The A Randomized Trial of Unruptured Brain AVMs&#x000a0;(ARUBA) trial identified a 2.2% annual risk of hemorrhage for unruptured cerebral AVMs.<xref ref-type="bibr" rid="article-17848.r14">[14]</xref>&#x000a0;The incidence of AVMs is 1.12 to 1.34 per 100,000 persons, which is significantly lower than cerebral aneurysms and other cerebral vascular malformations.<xref ref-type="bibr" rid="article-17848.r15">[15]</xref> There is no significant sex predisposition in adults.<xref ref-type="bibr" rid="article-17848.r6">[6]</xref>&#x000a0;A meta-analysis by Gross and Du published in 2013 reported the average age at presentation was 33.7 years old, with 36% to 38% of initial presentations in the form of a first-time hemorrhage.<xref ref-type="bibr" rid="article-17848.r16">[16]</xref>&#x000a0;</p>
        <p>There is a 0.02% incidence of&#x000a0;intracranial AMVs in the pediatric population without sex predilection. Pediatric spinal AVMs occur at 10% the rate of cerebral AVMs and have a five-fold predilection for boys.<xref ref-type="bibr" rid="article-17848.r4">[4]</xref><xref ref-type="bibr" rid="article-17848.r5">[5]</xref><bold>&#x000a0;</bold>Spinal AVMs commonly present clinically in the third decade, but patients aged less than 16 years&#x000a0;comprise 20% of cases.<xref ref-type="bibr" rid="article-17848.r4">[4]</xref></p>
      </sec>
      <sec id="article-17848.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Arteriovenous malformations are abnormal arterial to venous structural connections without capillaries or intervening cortical tissue. AVMs demonstrate nonphysiological hemodynamics, which affects the structure of the vessels within; they are typically high-flow, low-resistance shunts. Elevated hydrostatic pressure is a postulated contributing risk to hemorrhage.<xref ref-type="bibr" rid="article-17848.r13">[13]</xref>&#x000a0;Cerebral AVM rupture can lead to significant intraparenchymal hemorrhage or seizures secondary to microhemorrhages, resulting in cortical irritation. Spinal AVMs may rupture due to vascular instability. Arterialized venous architecture leads to vascular hypertension, which then exerts a mass effect on surrounding neural tissues and ischemic injury, leading&#x000a0;to progressive myelopathy, paresthesias, motor deficits, or bowel or bladder dysfunction.<xref ref-type="bibr" rid="article-17848.r17">[17]</xref></p>
      </sec>
      <sec id="article-17848.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>Histopathological examination may reveal a wide range of vascular wall composition, from mature arterial and venous structures to immature, thin, and hyalinized walls. Focal regions of wall hyalinization may protrude into vessel lumens. Intimal and smooth muscle layers are often malformed or disrupted.<xref ref-type="bibr" rid="article-17848.r6">[6]</xref>&#x000a0;Capillary architecture and intervening normal cortical tissue are not seen. Hemosiderin staining from prior microhemorrhages is very common, even without clinical symptoms.<xref ref-type="bibr" rid="article-17848.r6">[6]</xref></p>
      </sec>
      <sec id="article-17848.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Intracranial hemorrhage can result from a variety of pathologies, including chronic hypertension, amyloid angiopathy, vascular malformations, and trauma. Vascular malformations such as aneurysms and AVMs are more likely in patients presenting without trauma, aged second through sixth decades of life, with significant smoking history, and the simultaneous presence of other vascular malformations. The family history may include hereditary hemorrhagic telangiectasia or multiple vascular malformations.&#x000a0;</p>
        <p>The physical examination findings of a patient with an AVM are highly dependent on the location of the intracranial or spinal AVM and the presence or absence of acute hemorrhage. Intracranial AVMs in adults most commonly present with acute hemorrhage. Acute intracranial AVM hemorrhage may lead to weakness, sensory changes, cranial nerve palsies, seizures, or an altered level of consciousness, depending on location and mass effect. AMVs are responsible for 33% of intracranial hemorrhage in patients in the third and fourth decades of life; seizures are the second-most common presenting sign and are seen in 27% of patients.<xref ref-type="bibr" rid="article-17848.r2">[2]</xref>&#x000a0;Seizure presentation is more common with AVMs within the temporal lobes. Other less common presentations include focal neurologic deficits from mass effect, headaches, and vascular steal phenomena.&#x000a0;</p>
        <p>Two different symptomologies are typically seen in patients with spinal AVMs.&#x000a0;An acute hemorrhage presenting with the sudden onset of severe back pain may be accompanied by lower extremity motor weakness, sensory deficits such as paresthesias and numbness, and bladder or bowel dysfunction.&#x000a0;Alternatively, an unruptured spinal AVM may present with chronic progressive low back pain or lower extremity neurologic deficits secondary to progressive mass effect on the spinal cord.<xref ref-type="bibr" rid="article-17848.r18">[18]</xref>&#x000a0;Foix-Alajouanine syndrome has a characteristic presentation, defined as an acute or subacute&#x000a0;onset of myelopathy secondary to spinal cord venous thrombosis that induces spinal cord ischemic injury and necrosis.<xref ref-type="bibr" rid="article-17848.r5">[5]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-17848.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Imaging studies are essential in the evaluation of&#x000a0;intracranial and spinal AVMs. Patients presenting with headaches or neurologic deficits should undergo initial imaging via computed tomography (CT) of the head without contrast. A noncontrast head CT&#x000a0;can reveal acute intraparenchymal hemorrhage, subarachnoid hemorrhage, or intraventricular hemorrhage and rule out ischemic injury, lesions, masses, and other nonhemorrhagic pathologies. A noncontrast head CT may demonstrate only a subtle hyperdensity in a patient with an unruptured AVM, making detection difficult.<xref ref-type="bibr" rid="article-17848.r19">[19]</xref>&#x000a0;</p>
        <p>CT angiography provides excellent spatial resolution of vascular architecture. Valuable information about the AVM nidus structure, deep draining veins, possible aneurysms within the AVM, and significant feeding arteries can be visualized with CT angiography.<xref ref-type="bibr" rid="article-17848.r19">[19]</xref>&#x000a0;A study by Gross et al demonstrated that CT angiography detected 90% of cerebral AVMs, as opposed to magnetic resonance angiography (MRA), which was only 74% sensitive.<xref ref-type="bibr" rid="article-17848.r20">[20]</xref>&#x000a0;Digital subtraction catheter cerebral angiogram (DSA) is the gold standard for vascular imaging, with higher spatial and temporal sensitivity than noninvasive imaging modalities.<xref ref-type="bibr" rid="article-17848.r21">[21]</xref>&#x000a0;</p>
        <p>Magnetic resonance imaging (MRI) of the cervical, thoracic, and lumbar spine, with and without contrast, is the recommended initial diagnostic imaging evaluation for spinal AVMs. MRI can also exclude mass lesions, infectious pathology, spinal cord injury, discogenic mass effect, and epidural fluid collections.<xref ref-type="bibr" rid="article-17848.r18">[18]</xref>&#x000a0;Contrast-enhanced MRA provides significant spatial resolution and is a valuable adjunct before DSA for evaluating feeding vessels.<xref ref-type="bibr" rid="article-17848.r22">[22]</xref>&#x000a0;The gold standard for spinal vascular evaluation is spinal DSA, which provides a substantially more detailed view of vascular anatomic architecture and shows temporal flow through feeding and draining vessels.&#x000a0;&#x000a0;</p>
        <p>In addition to imaging modalities, an initial laboratory evaluation must be performed to determine patient coagulation status, renal function before contrast use in imaging modalities, and overall health status before considering possible interventions. These laboratory studies include but are not limited to a complete blood count with differential, comprehensive metabolic panel, internationalized normal ratio (INR), prothrombin time (PT), partial thromboplastin time (PTT), and type and screen for possible blood transfusion.&#x000a0;</p>
      </sec>
      <sec id="article-17848.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>
<bold>Spetzler-Martin Arteriovenous Malformation Grading System</bold>
</p>
        <p>The primary treatment modalities for&#x000a0;intracranial and spinal AVMs include surgical resection, endovascular embolization, stereotactic radiosurgery, or conservative management. The Spetzler-Martin AVM Grading System was developed in 1986 to determine the risk of morbidity and mortality of open surgical resection of&#x000a0;intracranial AVMs. The grading system requires a correlation between neuroimaging and cerebral angiographic findings. Graded neuroimaging findings include the size and site of the nidus, and graded angiographic findings include the size of the nidus and the pattern of venous drainage. Points are assigned for each finding, and a grade is calculated.<xref ref-type="bibr" rid="article-17848.r23">[23]</xref>&#x000a0;The assigned grade is equal to the sum of points from 3 categories; the minimum is Grade I (1 point), and the maximum is Grade V (5 points).<xref ref-type="bibr" rid="article-17848.r23">[23]</xref> There is an additional special designation of Grade VI.<xref ref-type="bibr" rid="article-17848.r23">[23]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p>Size of Nidus
<list list-type="bullet"><list-item><p>small, &#x0003c; 3 cm = 1 point</p></list-item><list-item><p>medium, 3 to 6 cm = 2 points</p></list-item><list-item><p>large, &#x0003e; 6 cm = 3 points</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>Venous Drainage
<list list-type="bullet"><list-item><p>superficial veins only = 0 points</p></list-item><list-item><p>deep veins = 1 point</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>Eloquence of Adjacent Brain
<list list-type="bullet"><list-item><p>noneloquent = 0 points</p></list-item><list-item><p>eloquent = 1 point</p></list-item></list>
</p>
          </list-item>
        </list>
        <p>The areas of the brain considered eloquent are the sensory, motor, language, or visual cortex; internal capsule; hypothalamus and thalamus; brainstem; superior, middle, and inferior cerebellar peduncles; and deep cerebellar nuclei.<xref ref-type="bibr" rid="article-17848.r23">[23]</xref>&#x000a0;Venous drainage is considered deep if any drainage is to the deep cerebral veins or cerebellar hemispheric veins unless they drain into the straight or transverse sinuses.<xref ref-type="bibr" rid="article-17848.r23">[23]</xref>&#x000a0;</p>
        <p>
<bold>Interventions for Intracranial Arteriovenous Malformations</bold>
</p>
        <p>Indications for urgent intervention include symptomatic or progressive neurologic deficits and intractable seizures not amenable to medical management. Often, surgical resection if preferred for superficial lesions, while radiosurgery is preferred for locations in the deep brain including the basal ganglia, thalamus and brainstem.<xref ref-type="bibr" rid="article-17848.r24">[24]</xref></p>
        <p>The risk of perioperative morbidity and mortality increases with increasing Spetzler-Martin grade. This grading system does not necessarily correlate with risks associated with endovascular embolization or stereotactic radiosurgery. However, Spetzler-Martin grades&#x000a0;I and II AVMs are usually managed with open surgical resection, grade III with endovascular embolization, and grades IV and V with stereotactic radiosurgery.<xref ref-type="bibr" rid="article-17848.r25">[25]</xref>&#x000a0;Endovascular embolization can be used to decrease the AVM nidus volume prior to stereotactic radiosurgery.<xref ref-type="bibr" rid="article-17848.r21">[21]</xref>&#x000a0;The ultimate goal of intervention is to obliterate the AVM nidus and all arteriovenous shunt locations. Grade VI AVMs are considered inoperable.<xref ref-type="bibr" rid="article-17848.r23">[23]</xref>&#x000a0;</p>
        <p>The risk of AVM rupture was evaluated in the A Randomized trial of Unruptured Brain Arteriovenous malformations (ARUBA) trial. This study revealed a decreased risk of stroke and mortality in patients managed conservatively versus patients who underwent interventional therapy.<xref ref-type="bibr" rid="article-17848.r13">[13]</xref>&#x000a0; The ARUBA trial compared medical management alone to medical management with prophylactic intervention, be it surgical, endovascular, radiosurgical, or a combination thereof. Out of&#x000a0;223 patients with a mean follow-up of 33.3 months, the primary endpoint of death from any cause or stroke occurred in 11 of 109 (10.1%) patients&#x000a0;in the medical group, compared with 35 of 114 (30.7%) in the interventional group. These data led to the discontinuation of the study after&#x000a0;6&#x000a0;years.<xref ref-type="bibr" rid="article-17848.r15">[15]</xref>&#x000a0;This study may overestimate the risk of surgery and underestimate the risk of medical management as surgical complications are usually evident in the short-term, while the risks of medical management are related to the long-term risks of rupture or mass effect.</p>
        <p>
<bold>Interventions for Spinal Arteriovenous Malformations</bold>
</p>
        <p>Treatment of spinal AVMs involves surgical resection, endovascular embolization, or a combination of methods. The main goal of treatment is to halt the progression of neurologic deficits secondary to mass effect or vascular steal phenomenon, as well as minimize permanent deficits.<xref ref-type="bibr" rid="article-17848.r5">[5]</xref>&#x000a0;Gross et al found a 10% annual rate of spinal AVM repeat hemorrhage, which has led to significant consideration for a more urgent intervention timeline.<xref ref-type="bibr" rid="article-17848.r26">[26]</xref>&#x000a0;Neurologic deficits after acute hemorrhage often improve with time, though some may have fixed neurologic deficits. In some cases, occlusion of an AVM may prevent the worsening of the current neurologic deficits.<xref ref-type="bibr" rid="article-17848.r27">[27]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-17848.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Intracranial AVMs can be diagnosed after symptomatic presentation, such as hemorrhage, mass effect, or seizures. Intracranial AVMs are also frequently diagnosed in asymptomatic patients&#x000a0;undergoing cranial imaging for an unrelated evaluation. The differential diagnosis of a patient presenting with an acute intracranial hemorrhage includes AVM, ruptured aneurysm, dural arteriovenous fistula, cerebral amyloid angiopathy, hemorrhagic tumor, lacunar hemorrhage secondary to hypertensive lipohyalinosis, and traumatic injury.&#x000a0;For patients presenting with seizures, the differential diagnosis includes pathologies that lead to cerebral edema, such as AVM, tumor, abscess, meningitis, and hydrocephalus, or neurologic etiologies of seizure disorders, including focal cortical dysplasia, mesial temporal sclerosis, and hereditary seizure disorders.&#x000a0;</p>
        <p>For patients with a spinal AVM who present with acute or progressive neurologic deficits and back pain, the differential diagnosis includes mass effect secondary to spinal cord tumor, disc herniation, osteomyelitis, diskitis, pathologic fractures, degenerative disk disease, acute traumatic injury, and vascular malformations. The majority of patients with spinal AVMs present after chronic progressive neurologic decline.<xref ref-type="bibr" rid="article-17848.r5">[5]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-17848.s11" sec-type="Radiation Oncology">
        <title>Radiation Oncology</title>
        <p>The Spetzler-MartinAVM Grading System is an essential tool for determining the appropriate management of intracerebral AVMs, be it open surgical resection, endovascular treatment, or a radiosurgical approach. AVMs smaller than 3cm in diameter with deep draining veins within the eloquent cortex are ideal for stereotactic radiosurgery as the morbidity and mortality of open surgical resection of these lesions are the highest. Stereotactic radiosurgery (SRS) can achieve a 70% to 90% obliteration rate in appropriately selected patients. The standard single dose in these cases is 22 Gy (50% isoline dose).<xref ref-type="bibr" rid="article-17848.r28">[28]</xref>&#x000a0;Radiosurgical treatment for AVMs measuring greater than 10 cm in diameter is still under investigation; multiple dose fractions are needed to deliver adequate radiation dose and minimize&#x000a0;adjacent cerebral edema. The complications of SRS for AVM treatment include seizure and hemorrhage. The primary consideration of SRS in AVM management is that obliteration and radiation effects take 2 to 3 years to occur.<xref ref-type="bibr" rid="article-17848.r28">[28]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-17848.s12" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The prognosis of an intracranial AVM is dependent on a history of rupture. Unruptured AVMs have a 2.2% annual risk of rupture, and previously ruptured AVMs have a 4% annual risk.<xref ref-type="bibr" rid="article-17848.r28">[28]</xref>&#x000a0;In 2019, Fengali et al introduced a predictive&#x000a0;index to stratify the risk of hemorrhage, called the R2eED AVM Score. Factors that&#x000a0;increased risk were a small nidus size, non-White ethnicity, deep location, the presence of a single arterial feeder, and deep venous drainage.<xref ref-type="bibr" rid="article-17848.r29">[29]</xref>&#x000a0;The volume and location of rupture determine residual neurologic deficit burden and functional recovery.&#x000a0;</p>
      </sec>
      <sec id="article-17848.s13" sec-type="Complications">
        <title>Complications</title>
        <p>There is debate over the management of intracranial AVMs, as the risk of surgical treatment complications must be weighed against the risk of lesion rupture or repeat rupture. Surgical complications include stroke, intracranial hemorrhage, seizure, and death. The ARUBA trial evaluated the cumulative outcomes of intervention for unruptured AVMs compared to outcomes of observation, with a significantly increased&#x000a0;rate of death from any cause or stroke in the intervention group.<xref ref-type="bibr" rid="article-17848.r14">[14]</xref>&#x000a0;Other complications of intracranial AVMs include the vascular steal phenomenon and mass effect.</p>
        <p>Complications of spinal AVMs include rupture with subsequent hemorrhage and neurologic deficits secondary to progressive mass effect. &#x000a0;</p>
      </sec>
      <sec id="article-17848.s14" sec-type="Consultations">
        <title>Consultations</title>
        <p>Patients presenting with intracranial or spinal hemorrhage and radiologic evidence of an AVM require neurocritical care team consultation for the management of blood pressure parameters, neurologic observation, and overall critical management during the posthemorrhagic period. Neurosurgical consultation at the initial diagnosis of hemorrhage is required. Patients with&#x000a0;radiological&#x000a0;evidence of an intracranial or spinal AVM require neurosurgical consultation for lesion evaluation, risk stratification, and development of appropriate intervention plans. If patients present with seizures, neurologic consultation is also beneficial for an optimal antiepileptic medication regimen.&#x000a0;</p>
      </sec>
      <sec id="article-17848.s15" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Arteriovenous malformations are congenital abnormal connections between arteries and veins without normal tissue between them. Patients with AVMs are often asymptomatic until the third or fourth decade of life. Intracranial AVMs can cause seizures from mass effect or small hemorrhages, weakness or numbness from mass effect, or rupture with significant hemorrhage. The location of the AVM determines which neurologic symptoms may present. The treatment of intracranial AVMs&#x000a0;is dependent on specific characteristics of the lesion, including its size, location, and the presence of deep draining veins.</p>
        <p>Asymptomatic AVMs are often diagnosed during cranial or spinal imaging for evaluation of other conditions, such as headaches or back pain. Patients with incidentally diagnosed intracranial or spinal AVMs should meet with a neurosurgeon to discuss risks and possible disease progression with observation. Neurosurgical observation over time via neurologic examinations and surveillance imaging is highly recommended.</p>
        <p>The majority of AVMs are sporadic, although a history of certain disorders such as hereditary hemorrhagic telangiectasia&#x000a0;may increase the risk of multiple AVMs. Treatment options for intracranial AVMs include surveillance with imaging, stereotactic radiosurgery, endovascular embolization, and open surgical resection. Treatment options for spinal AVMs surveillance with imaging, endovascular embolization, or open surgical resection.&#x000a0;</p>
      </sec>
      <sec id="article-17848.s16" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Intracranial AVMs are often significant management challenges; each treatment plan is unique based on lesion characteristics and presentation. Patients with acute hemorrhage or ischemic injury can present with localized or diffuse symptoms such as severe headache, nausea, vision changes, weakness, gait instability, confusion, or change in consciousness. Employing a multidisciplinary team approach optimizes patient outcomes.</p>
        <p>Emergency department providers are critical for the initial identification of patients who present with symptoms consistent with possible vascular lesions and initiate appropriate labwork, imaging, and medical management, such as blood pressure control and reversal of anticoagulation medications in the setting of hemorrhage. Radiologists provide valuable expertise during image analysis to determine the extent and characteristics of vascular abnormalities critical in decision-making for management and possible intervention. Nurses&#x000a0;monitor patient vitals, neurologic status, and other changes in patient condition. Detailed pharmacological knowledge is necessary to provide appropriate antiplatelet or anticoagulation reversal agents to decrease the risk of further hemorrhage. Pharmacists ensure appropriate antiplatelet or anticoagulation medication reversal agents, antihypertensive regimens, and analgesic medications for symptom management. Neurologists assist with seizure management and antiepileptic medication regimen, as well as acute and chronic stroke management. The critical care team coordinates multiple medical comorbidities and is essential to medical optimization during the acute and subacute periods after symptomatic onset. The neurosurgical, endovascular, and radiation oncology services evaluate, determine, and perform appropriate interventions based on AVM and patient characteristics.&#x000a0;In addition, conversations with the patient and their&#x000a0;caregivers regarding diagnosis and decisions regarding treatment plans&#x000a0;must be shared with the multidisciplinary team in&#x000a0;order to coordinate cohesive patient-centered care and facilitate successful outcomes.</p>
        <p>For asymptomatic lesions, outpatient neurosurgical evaluation is essential to determine an appropriate patient-centered management plan. If the patient has a history of headaches or seizures not related to a known cerebral AVM, outpatient neurologic evaluation and management are needed to optimize the treatment regimen to distinguish between acute AVM symptoms and historical disease presentations.&#x000a0;</p>
      </sec>
      <sec id="article-17848.s17">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=17848&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=17848">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/neurology/arteriovenous-malformations-of-the-central-nervous-system/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=17848">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/17848/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=17848">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-17848.s18">
        <title>References</title>
        <ref id="article-17848.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rutledge</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Cooke</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Hetts</surname>
                <given-names>SW</given-names>
              </name>
              <name>
                <surname>Abla</surname>
                <given-names>AA</given-names>
              </name>
            </person-group>
            <article-title>Brain arteriovenous malformations.</article-title>
            <source>Handb Clin Neurol</source>
            <year>2021</year>
            <volume>176</volume>
            <fpage>171</fpage>
            <page-range>171-178</page-range>
            <pub-id pub-id-type="pmid">33272394</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17848.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Can</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gross</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Du</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>The natural history of cerebral arteriovenous malformations.</article-title>
            <source>Handb Clin Neurol</source>
            <year>2017</year>
            <volume>143</volume>
            <fpage>15</fpage>
            <page-range>15-24</page-range>
            <pub-id pub-id-type="pmid">28552137</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17848.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Takai</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Spinal Arteriovenous Shunts: Angioarchitecture and Historical Changes in Classification.</article-title>
            <source>Neurol Med Chir (Tokyo)</source>
            <year>2017</year>
            <month>Jul</month>
            <day>15</day>
            <volume>57</volume>
            <issue>7</issue>
            <fpage>356</fpage>
            <page-range>356-365</page-range>
            <pub-id pub-id-type="pmid">28515372</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17848.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>da Costa</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Dehdashti</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>terBrugge</surname>
                <given-names>KG</given-names>
              </name>
            </person-group>
            <article-title>Spinal cord vascular shunts: spinal cord vascular malformations and dural arteriovenous fistulas.</article-title>
            <source>Neurosurg Focus</source>
            <year>2009</year>
            <month>Jan</month>
            <volume>26</volume>
            <issue>1</issue>
            <fpage>E6</fpage>
            <pub-id pub-id-type="pmid">19119892</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17848.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Flores</surname>
                <given-names>BC</given-names>
              </name>
              <name>
                <surname>Klinger</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>White</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Batjer</surname>
                <given-names>HH</given-names>
              </name>
            </person-group>
            <article-title>Spinal vascular malformations: treatment strategies and outcome.</article-title>
            <source>Neurosurg Rev</source>
            <year>2017</year>
            <month>Jan</month>
            <volume>40</volume>
            <issue>1</issue>
            <fpage>15</fpage>
            <page-range>15-28</page-range>
            <pub-id pub-id-type="pmid">27075861</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17848.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McCormick</surname>
                <given-names>WF</given-names>
              </name>
            </person-group>
            <article-title>The pathology of vascular ("arteriovenous") malformations.</article-title>
            <source>J Neurosurg</source>
            <year>1966</year>
            <month>Apr</month>
            <volume>24</volume>
            <issue>4</issue>
            <fpage>807</fpage>
            <page-range>807-16</page-range>
            <pub-id pub-id-type="pmid">5934138</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17848.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Barbosa Do Prado</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Han</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Oh</surname>
                <given-names>SP</given-names>
              </name>
              <name>
                <surname>Su</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Recent Advances in Basic Research for Brain Arteriovenous Malformation.</article-title>
            <source>Int J Mol Sci</source>
            <year>2019</year>
            <month>Oct</month>
            <day>25</day>
            <volume>20</volume>
            <issue>21</issue>
            <pub-id pub-id-type="pmid">31731545</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17848.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nikolaev</surname>
                <given-names>SI</given-names>
              </name>
              <name>
                <surname>Vetiska</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bonilla</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Boudreau</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Jauhiainen</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Rezai Jahromi</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Khyzha</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>DiStefano</surname>
                <given-names>PV</given-names>
              </name>
              <name>
                <surname>Suutarinen</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kiehl</surname>
                <given-names>TR</given-names>
              </name>
              <name>
                <surname>Mendes Pereira</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Herman</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Krings</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Andrade-Barazarte</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Tung</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Valiante</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Zadeh</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Tymianski</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rauramaa</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Yl&#x000e4;-Herttuala</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Wythe</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Antonarakis</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Fr&#x000f6;sen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Fish</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Radovanovic</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Somatic Activating KRAS Mutations in Arteriovenous Malformations of the Brain.</article-title>
            <source>N Engl J Med</source>
            <year>2018</year>
            <month>Jan</month>
            <day>18</day>
            <volume>378</volume>
            <issue>3</issue>
            <fpage>250</fpage>
            <page-range>250-261</page-range>
            <pub-id pub-id-type="pmid">29298116</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17848.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Walcott</surname>
                <given-names>BP</given-names>
              </name>
              <name>
                <surname>Winkler</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Zhou</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Birk</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Guo</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Koch</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Stapleton</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Spiegelman</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Dionne-Laporte</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Dion</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Kahle</surname>
                <given-names>KT</given-names>
              </name>
              <name>
                <surname>Rouleau</surname>
                <given-names>GA</given-names>
              </name>
              <name>
                <surname>Lawton</surname>
                <given-names>MT</given-names>
              </name>
            </person-group>
            <article-title>Identification of a rare <italic>BMP</italic> pathway mutation in a non-syndromic human brain arteriovenous malformation via exome sequencing.</article-title>
            <source>Hum Genome Var</source>
            <year>2018</year>
            <volume>5</volume>
            <fpage>18001</fpage>
            <pub-id pub-id-type="pmid">29844917</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17848.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hill-Felberg</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>HH</given-names>
              </name>
              <name>
                <surname>Toms</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Dehdashti</surname>
                <given-names>AR</given-names>
              </name>
            </person-group>
            <article-title>Notch receptor expression in human brain arteriovenous malformations.</article-title>
            <source>J Cell Mol Med</source>
            <year>2015</year>
            <month>Aug</month>
            <volume>19</volume>
            <issue>8</issue>
            <fpage>1986</fpage>
            <page-range>1986-93</page-range>
            <pub-id pub-id-type="pmid">25846406</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17848.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hauer</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Kleinloog</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Giuliani</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Rinkel</surname>
                <given-names>GJE</given-names>
              </name>
              <name>
                <surname>de Kort</surname>
                <given-names>GA</given-names>
              </name>
              <name>
                <surname>Berkelbach van der Sprenkel</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>van der Zwan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gosselaar</surname>
                <given-names>PH</given-names>
              </name>
              <name>
                <surname>van Rijen</surname>
                <given-names>PC</given-names>
              </name>
              <name>
                <surname>de Boer-Bergsma</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Deelen</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Swertz</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>De Muynck</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Van Damme</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Veldink</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Ruigrok</surname>
                <given-names>YM</given-names>
              </name>
              <name>
                <surname>Klijn</surname>
                <given-names>CJM</given-names>
              </name>
            </person-group>
            <article-title>RNA-Sequencing Highlights Inflammation and Impaired Integrity of the Vascular Wall in Brain Arteriovenous Malformations.</article-title>
            <source>Stroke</source>
            <year>2020</year>
            <month>Jan</month>
            <volume>51</volume>
            <issue>1</issue>
            <fpage>268</fpage>
            <page-range>268-274</page-range>
            <pub-id pub-id-type="pmid">31795902</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17848.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bao</surname>
                <given-names>YH</given-names>
              </name>
              <name>
                <surname>Ling</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Classification and therapeutic modalities of spinal vascular malformations in 80 patients.</article-title>
            <source>Neurosurgery</source>
            <year>1997</year>
            <month>Jan</month>
            <volume>40</volume>
            <issue>1</issue>
            <fpage>75</fpage>
            <page-range>75-81</page-range>
            <pub-id pub-id-type="pmid">8971827</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17848.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shaligram</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Winkler</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Cooke</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Su</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Risk factors for hemorrhage of brain arteriovenous malformation.</article-title>
            <source>CNS Neurosci Ther</source>
            <year>2019</year>
            <month>Oct</month>
            <volume>25</volume>
            <issue>10</issue>
            <fpage>1085</fpage>
            <page-range>1085-1095</page-range>
            <pub-id pub-id-type="pmid">31359618</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17848.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mohr</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Parides</surname>
                <given-names>MK</given-names>
              </name>
              <name>
                <surname>Stapf</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Moquete</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Moy</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Overbey</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Al-Shahi Salman</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Vicaut</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Young</surname>
                <given-names>WL</given-names>
              </name>
              <name>
                <surname>Houdart</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Cordonnier</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Stefani</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Hartmann</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>von Kummer</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Biondi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Berkefeld</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Klijn</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Harkness</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Libman</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Barreau</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Moskowitz</surname>
                <given-names>AJ</given-names>
              </name>
              <collab>international ARUBA investigators</collab>
            </person-group>
            <article-title>Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA): a multicentre, non-blinded, randomised trial.</article-title>
            <source>Lancet</source>
            <year>2014</year>
            <month>Feb</month>
            <day>15</day>
            <volume>383</volume>
            <issue>9917</issue>
            <fpage>614</fpage>
            <page-range>614-21</page-range>
            <pub-id pub-id-type="pmid">24268105</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17848.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Al-Shahi</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Bhattacharya</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Currie</surname>
                <given-names>DG</given-names>
              </name>
              <name>
                <surname>Papanastassiou</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Ritchie</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Roberts</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Sellar</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Warlow</surname>
                <given-names>CP</given-names>
              </name>
              <collab>Scottish Intracranial Vascular Malformation Study Collaborators</collab>
            </person-group>
            <article-title>Scottish Intracranial Vascular Malformation Study (SIVMS): evaluation of methods, ICD-10 coding, and potential sources of bias in a prospective, population-based cohort.</article-title>
            <source>Stroke</source>
            <year>2003</year>
            <month>May</month>
            <volume>34</volume>
            <issue>5</issue>
            <fpage>1156</fpage>
            <page-range>1156-62</page-range>
            <pub-id pub-id-type="pmid">12702840</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17848.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gross</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Du</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Natural history of cerebral arteriovenous malformations: a meta-analysis.</article-title>
            <source>J Neurosurg</source>
            <year>2013</year>
            <month>Feb</month>
            <volume>118</volume>
            <issue>2</issue>
            <fpage>437</fpage>
            <page-range>437-43</page-range>
            <pub-id pub-id-type="pmid">23198804</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17848.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Endo</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Endo</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Sato</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Matsumoto</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Tominaga</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Surgical and Endovascular Treatment for Spinal Arteriovenous Malformations.</article-title>
            <source>Neurol Med Chir (Tokyo)</source>
            <year>2016</year>
            <month>Aug</month>
            <day>15</day>
            <volume>56</volume>
            <issue>8</issue>
            <fpage>457</fpage>
            <page-range>457-64</page-range>
            <pub-id pub-id-type="pmid">26948701</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17848.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Udelhoven</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kettner</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Reith</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>[Spinal arteriovenous malformations].</article-title>
            <source>Radiologie (Heidelb)</source>
            <year>2022</year>
            <month>Aug</month>
            <volume>62</volume>
            <issue>8</issue>
            <fpage>666</fpage>
            <page-range>666-670</page-range>
            <pub-id pub-id-type="pmid">35768523</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17848.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tranvinh</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Heit</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Hacein-Bey</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Provenzale</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Wintermark</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Contemporary Imaging of Cerebral Arteriovenous Malformations.</article-title>
            <source>AJR Am J Roentgenol</source>
            <year>2017</year>
            <month>Jun</month>
            <volume>208</volume>
            <issue>6</issue>
            <fpage>1320</fpage>
            <page-range>1320-1330</page-range>
            <pub-id pub-id-type="pmid">28267351</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17848.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gross</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Frerichs</surname>
                <given-names>KU</given-names>
              </name>
              <name>
                <surname>Du</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Sensitivity of CT angiography, T2-weighted MRI, and magnetic resonance angiography in detecting cerebral arteriovenous malformations and associated aneurysms.</article-title>
            <source>J Clin Neurosci</source>
            <year>2012</year>
            <month>Aug</month>
            <volume>19</volume>
            <issue>8</issue>
            <fpage>1093</fpage>
            <page-range>1093-5</page-range>
            <pub-id pub-id-type="pmid">22705129</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17848.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>De Leacy</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Ansari</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Schirmer</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Cooke</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Prestigiacomo</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Bulsara</surname>
                <given-names>KR</given-names>
              </name>
              <name>
                <surname>Hetts</surname>
                <given-names>SW</given-names>
              </name>
              <collab>SNIS Standards and Guidelines Committee, SNIS Board of Directors</collab>
            </person-group>
            <article-title>Endovascular treatment in the multimodality management of brain arteriovenous malformations: report of the Society of NeuroInterventional Surgery Standards and Guidelines Committee.</article-title>
            <source>J Neurointerv Surg</source>
            <year>2022</year>
            <month>Nov</month>
            <volume>14</volume>
            <issue>11</issue>
            <fpage>1118</fpage>
            <page-range>1118-1124</page-range>
            <pub-id pub-id-type="pmid">35414599</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17848.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tanitame</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Tanitame</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Awai</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Clinical utility of optimized three-dimensional T1-, T2-, and T2*-weighted sequences in spinal magnetic resonance imaging.</article-title>
            <source>Jpn J Radiol</source>
            <year>2017</year>
            <month>Apr</month>
            <volume>35</volume>
            <issue>4</issue>
            <fpage>135</fpage>
            <page-range>135-144</page-range>
            <pub-id pub-id-type="pmid">28233194</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17848.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ryu</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Ishikawa</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kawamata</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Multimodal Treatment Strategy for Spetzler-Martin Grade III Arteriovenous Malformations of the Brain.</article-title>
            <source>Neurol Med Chir (Tokyo)</source>
            <year>2017</year>
            <month>Feb</month>
            <day>15</day>
            <volume>57</volume>
            <issue>2</issue>
            <fpage>73</fpage>
            <page-range>73-81</page-range>
            <pub-id pub-id-type="pmid">27169498</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17848.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hasegawa</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Yamamoto</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Shin</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Barfod</surname>
                <given-names>BE</given-names>
              </name>
            </person-group>
            <article-title>Gamma Knife Radiosurgery For Brain Vascular Malformations: Current Evidence And Future Tasks.</article-title>
            <source>Ther Clin Risk Manag</source>
            <year>2019</year>
            <volume>15</volume>
            <fpage>1351</fpage>
            <page-range>1351-1367</page-range>
            <pub-id pub-id-type="pmid">31819462</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17848.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Spetzler</surname>
                <given-names>RF</given-names>
              </name>
              <name>
                <surname>Ponce</surname>
                <given-names>FA</given-names>
              </name>
            </person-group>
            <article-title>A 3-tier classification of cerebral arteriovenous malformations. Clinical article.</article-title>
            <source>J Neurosurg</source>
            <year>2011</year>
            <month>Mar</month>
            <volume>114</volume>
            <issue>3</issue>
            <fpage>842</fpage>
            <page-range>842-9</page-range>
            <pub-id pub-id-type="pmid">20932095</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17848.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gross</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Du</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Spinal glomus (type II) arteriovenous malformations: a pooled analysis of hemorrhage risk and results of intervention.</article-title>
            <source>Neurosurgery</source>
            <year>2013</year>
            <month>Jan</month>
            <volume>72</volume>
            <issue>1</issue>
            <fpage>25</fpage>
            <page-range>25-32; discussion 32</page-range>
            <pub-id pub-id-type="pmid">23096418</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17848.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brinjikji</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Lanzino</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Endovascular treatment of spinal arteriovenous malformations.</article-title>
            <source>Handb Clin Neurol</source>
            <year>2017</year>
            <volume>143</volume>
            <fpage>161</fpage>
            <page-range>161-174</page-range>
            <pub-id pub-id-type="pmid">28552139</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17848.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Byun</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kwon</surname>
                <given-names>DH</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>DH</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Ahn</surname>
                <given-names>JS</given-names>
              </name>
            </person-group>
            <article-title>Radiosurgery for Cerebral Arteriovenous Malformation (AVM) : Current Treatment Strategy and Radiosurgical Technique for Large Cerebral AVM.</article-title>
            <source>J Korean Neurosurg Soc</source>
            <year>2020</year>
            <month>Jul</month>
            <volume>63</volume>
            <issue>4</issue>
            <fpage>415</fpage>
            <page-range>415-426</page-range>
            <pub-id pub-id-type="pmid">32423182</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17848.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Feghali</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Xu</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Liew</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>McDougall</surname>
                <given-names>CG</given-names>
              </name>
              <name>
                <surname>Caplan</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Tamargo</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>R<sub>2</sub>eD AVM Score.</article-title>
            <source>Stroke</source>
            <year>2019</year>
            <month>Jul</month>
            <volume>50</volume>
            <issue>7</issue>
            <fpage>1703</fpage>
            <page-range>1703-1710</page-range>
            <pub-id pub-id-type="pmid">31167618</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
